Seeking Alpha

Lev Pharmaceutical (LEVP.OB)

()

Comments on LEVP.OB

  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals [View article]
    Solid growth of Cinryze sales from Viropharma just reported this morning. In terms of looking ahead, DYAX is next up on the plate for... More »
    Comment by Dan Weiss
    Jul 29 13:24 pm |
    Rating: 0 0
  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals [View article]
    CSL Behring is expected to have a decision on its acute version early next year but the odds of approval at this point from my... More »
    Comment by Dan Weiss
    Oct 16 23:58 pm |
    Rating: 0 0
  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals [View article]
    You didn't mention an important factor; that is CSL Behring has it's version of Cinryze (C1INH) in the FDA's pipeline and has an... More »
    Comment by kahuna
    Oct 13 13:40 pm |
    Rating: 0 0
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair [View article]
    FDA approval just granted on the prophylaxis side after the close today. This is clearly a major positive for LEV as the value should be... More »
    Comment by Dan Weiss
    Oct 10 18:37 pm |
    Rating: 0 0
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair [View article]
    Ive been asked via email about what my thinking is on odds of each scenario and I would put #1 at a bit higher than 95% with about a... More »
    Comment by Dan Weiss
    Oct 9 17:07 pm |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    Hey, Value Geek, don't feel bad, I thought your article made some excellent points.
    Comment by oldcurmudgeon2
    Aug 20 15:10 pm |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    bravo uncommon sense....finally someone with brains posting somthing that makes sense!!!
    Comment by jodabutcher
    Aug 19 16:51 pm |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    I'm an intern at an M&A arb hedge fund and I looked at this deal pretty closely. First of all, the guy who wrote this article needs to... More »
    Comment by REITRider
    Aug 15 20:42 pm |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    you are wron...period! Viropharma has the option to back out completely if the fda doesn't approve and you didn't respond to my comment... More »
    Comment by jodabutcher
    Aug 5 11:08 am |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    Genedr : FDA will almost certainly approve Cinryze, given its wide use and excellent safety record in Europe. From the press releases... More »
    Comment by Value Geek
    Aug 4 10:36 am |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    Your article missed the mark by a wide margin. Number one, its incredibly ignorant to assume a. someone can "feel" an attack coming and... More »
    Aug 3 15:57 pm |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    You are ill informed and should read closely before you write your articles....If the deal doesn't turn out great Viropharma will only... More »
    Comment by jodabutcher
    Aug 3 10:20 am |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    You are ill informed and should read closely before you write your articles....If the deal doesn't turn out great Viropharma will only... More »
    Comment by jodabutcher
    Aug 3 10:19 am |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    I agree with most of your analysis. However, what is your take on the fact that VPHM will likely wait on closing of this deal until the... More »
    Comment by Genedr
    Aug 3 08:11 am |
    Rating: 0 0
  • ViroPharma: Lev Acquisition Appraisal [View article]
    I agree with most of your analysis. However, what is your take on the fact that VPHM will likely wait on closing of this deal until the... More »
    Comment by Genedr
    Aug 3 08:11 am |
    Rating: 0 0